Advancing Cancer Research Worldwide
ECOG-ACRIN Cancer Research Group (ecog-acrin.org) scores 78 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Non-profit brands, Education brands, in the 64th percentile of 19412 Healthcare brands.
ECOG-ACRIN Cancer Research Group is a nonprofit healthcare and research organization headquartered in Philadelphia, founded in 2012. It operates a worldwide network of approximately 1,300 academic and community-based cancer centers and hospitals that collaborate on large-scale, multidisciplinary clinical trials and translational research. Its mission is to improve outcomes for cancer patients by advancing scientific discovery into clinical practice through rigorous, cooperative oncology research.
| Brand Name | ECOG-ACRIN Cancer Research Group |
|---|---|
| Domain | ecog-acrin.org |
| Industry | Healthcare, Non-profit |
| Founded | 2012 |
| Headquarters | Philadelphia, United States |
| Main Competitors | SWOG Cancer Research Network (76/100), Alliance for Clinical Trials in Oncology (68/100), NRG Oncology (75/100), Children's Oncology Group (85/100), Canadian Cancer Trials Group |
Moz Domain Authority 51/100 vs category average 40 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #1,210,243 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "ECOG-ACRIN Cancer Research Group is a worldwide network of 1300 academic and community-based cancer centers and hospitals." (Meta description: 17 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, + Microdata, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost.
Social footprint: verified profiles on YouTube, X (Twitter), Facebook, Instagram; no detected presence on LinkedIn, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is ECOG-ACRIN Cancer Research Group?", Claude could identify the brand as of October 2026. ECOG-ACRIN Cancer Research Group is a National Cancer Institute-funded cooperative group that designs and conducts large-scale cancer clinical trials, formed from the merger of the Eastern Cooperative Oncology Group and the American College of Radiology Imaging Network. Best known for Running multi-institutional oncology clinical trials as part of the NCI's National Clinical Trials Network.
When asked "Best brands similar to ECOG-ACRIN Cancer Research Group?", Claude would recommend ECOG-ACRIN Cancer Research Group as of October 2026. It's a major, well-established cooperative group in cancer research, so it's a natural mention alongside other NCI-funded trial networks like SWOG or NRG Oncology.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
ECOG-ACRIN Cancer Research Group's main competitors in Healthcare: SWOG Cancer Research Network (76/100), Alliance for Clinical Trials in Oncology (68/100), NRG Oncology (75/100), Children's Oncology Group (85/100).
Sources: Brand Analyzer scan
ECOG-ACRIN Cancer Research Group has limited AI-search visibility, scoring 39/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 53, recommendation 56). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
ECOG-ACRIN Cancer Research Group was founded in 2012. ECOG-ACRIN Cancer Research Group operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
ECOG-ACRIN Cancer Research Group scores 56/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
ECOG-ACRIN Cancer Research Group is a nonprofit healthcare organization headquartered in Philadelphia, founded in 2012, that operates a worldwide network of about 1,300 academic and community-based cancer centers and hospitals. It functions as a cooperative clinical trials group dedicated to conducting large-scale cancer research studies.
ECOG-ACRIN Cancer Research Group can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
ECOG-ACRIN offers clinical trial design and coordination, translational cancer research programs, and a collaborative infrastructure connecting cancer centers and hospitals globally. Its core 'service' is organizing and managing multidisciplinary cancer studies rather than commercial products.
ECOG-ACRIN is known for leading cooperative, multi-institutional cancer clinical trials that bring together a worldwide network of roughly 1,300 cancer centers and hospitals to translate scientific discoveries into improved patient care.
ECOG-ACRIN's network and research are used by oncology researchers, physicians, academic and community-based medical institutions, and ultimately benefit cancer patients and caregivers through the clinical trials and findings it produces.
ECOG-ACRIN Cancer Research Group scores 39/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
ECOG-ACRIN Cancer Research Group has a weak AI-visibility profile at 39/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (56/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #1,210,243 (Tranco) and a Moz Domain Authority of 51/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify ECOG-ACRIN Cancer Research Group from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to ECOG-ACRIN Cancer Research Group: eClinical Solutions (78/100), The Stepping Stones Group (78/100), Edinburgh Leisure (78/100), Effective School Solutions (78/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.